헬스케어

Since its establishment in 2022, Biostream Test & Analysis Center has conducted quality inspection tests on domestically licensed pharmaceutical raw
materials and finished products based on the Korean Pharmacopoeia. All employees are dedicated to achieving designation as a "Drug Testing and
Inspection Institution" by the Ministry of Food and Drug Safety to ensure the reliability of test results.

We aim to become the leading pharmaceutical analysis center in the Republic of Korea by continuously investing in R&D based on customer requirements.
We are introducing advanced equipment such as isolators, LC, and GC and plan to establish an analysis system that aligns with global trends.

Additionally, we will establish Data Integrity-based testing methodologies suitable for cutting-edge analytical instruments by leveraging our extensive
knowledge and superior technology. Through these efforts, we will position ourselves as the top testing institution in Korea with international competitiveness.